X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
chemistry (41) 41
metallurgy (41) 41
metallurgy of iron (32) 32
processing of pig-iron, e.g. refining, manufacture ofwrought-iron or steel (28) 28
treatment in molten state of ferrous alloys (28) 28
ferrous or non-ferrous alloys (20) 20
treatment of alloys or non-ferrous metals (20) 20
alloys (19) 19
index medicus (17) 17
humans (16) 16
performing operations (11) 11
transporting (11) 11
basic electric elements (10) 10
electricity (10) 10
female (9) 9
male (9) 9
acute myeloid leukemia (8) 8
cancer (8) 8
hematology (8) 8
inductances (8) 8
magnets (8) 8
selection of materials for their magnetic properties (8) 8
transformers (8) 8
land vehicles for travelling otherwise than on rails (7) 7
leukemia (7) 7
motor vehicles (7) 7
prognosis (7) 7
servicing, cleaning, repairing, supporting, lifting, ormanoeuvring of vehicles, not otherwise provided for (7) 7
trailers (7) 7
vehicles in general (7) 7
vehicles, vehicle fittings, or vehicle parts, not otherwiseprovided for (7) 7
adolescent (6) 6
child (6) 6
expression (6) 6
gene expression (6) 6
myeloid leukemia (6) 6
pediatrics (6) 6
child, preschool (5) 5
genetic aspects (5) 5
leukemia, myeloid, acute - genetics (5) 5
apoptosis (4) 4
cell death (4) 4
hemic and lymphatic diseases (4) 4
infant (4) 4
leukemia, myeloid, acute - mortality (4) 4
leukemia, myeloid, acute - pathology (4) 4
multidisciplinary sciences (4) 4
mutations (4) 4
patients (4) 4
runx1 protein (4) 4
transcription factors (4) 4
abrasive or related blasting with particulate material (3) 3
activation (3) 3
adding materials to fuels or fires to reduce smoke orundesirable deposits or to facilitate soot removal (3) 3
air (3) 3
aml (3) 3
analysis (3) 3
binding (3) 3
blasting (3) 3
cell line, tumor (3) 3
chemotherapy (3) 3
children (3) 3
clear cell-type renal cell carcinoma (3) 3
clonal deletion (3) 3
combustion apparatus (3) 3
combustion processes (3) 3
firelighters (3) 3
fuels (3) 3
fuels not otherwise provided for (3) 3
general devices for heat treatment of ferrous or non-ferrousmetals or alloys (3) 3
genes (3) 3
grinding (3) 3
health aspects (3) 3
heating (3) 3
hypoxia (3) 3
hypoxia-inducible factors (3) 3
leukemia, myeloid, acute - diagnosis (3) 3
leukemia, myeloid, acute - drug therapy (3) 3
leukemia, myeloid, acute - metabolism (3) 3
lighting (3) 3
liquefied petroleum gas (3) 3
lubricants (3) 3
lymphoma (3) 3
making metal malleable by decarburisation, tempering or othertreatments (3) 3
mechanical engineering (3) 3
methodsor apparatus for combustion using fluid fuelor solid fuel suspended in (3) 3
middle aged (3) 3
modifying the physical structure of ferrous metals (3) 3
mutation (3) 3
natural gas (3) 3
oncology (3) 3
peat (3) 3
petroleum, gas or coke industries (3) 3
polishing (3) 3
prognostic factor (3) 3
relapse (3) 3
respiration (3) 3
retrospective studies (3) 3
survival (3) 3
synthetic natural gas obtained by processes not covered bysubclasses c10g, c10k (3) 3
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (103) 103
French (10) 10
German (5) 5
Chinese (2) 2
Italian (2) 2
Japanese (2) 2
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Internal Medicine, ISSN 0918-2918, 2018, Volume 57, Issue 11, pp. 1631 - 1636
Diffuse pulmonary ossification (DPO) is a rare disease characterized by metaplastic bone formation in the lung. There are few reports with a long-term... 
restrictive ventilatory impairment | prognosis | pulmonary ossification | Pulmonary ossification | Restrictive ventilatory impairment | Prognosis | MEDICINE, GENERAL & INTERNAL | Bone growth | Dyspnea | Computed tomography | Lungs | Impairment | Respiration | Osteogenesis | Cough | Age | Nodules | Ossification | Case Report
Journal Article
Pediatrics International, ISSN 1328-8067, 01/2018, Volume 60, Issue 1, pp. 47 - 51
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 06/2017, Volume 127, Issue 7, pp. 2815 - 2828
Journal Article
Journal Article
Scientific Reports, ISSN 2045-2322, 12/2017, Volume 7, Issue 1, pp. 3816 - 14
Journal Article
Journal Article
Pediatrics International, ISSN 1328-8067, 10/2017, Volume 59, Issue 10, pp. 1046 - 1052
Background The combination of fludarabine (Flu), high‐dose cytarabine (Ara‐C) and granulocyte colony‐stimulating factor (G‐CSF; FLAG), with anthracyclines has... 
FLAG‐IDA | minimal residual disease | acute myeloid leukemia | children | relapse | FLAG-IDA | CYTOSINE-ARABINOSIDE | BONE-MARROW-TRANSPLANTATION | ACUTE MYELOGENOUS LEUKEMIA | RANDOMIZED-TRIAL | HIGH-DOSE CYTARABINE | G-CSF | LIPOSOMAL DAUNORUBICIN | PHASE-II TRIAL | INITIAL THERAPY | PEDIATRICS | Recombinant Proteins - therapeutic use | Recurrence | Drug Administration Schedule | Cytarabine - therapeutic use | Humans | Child, Preschool | Male | Treatment Outcome | Antineoplastic Agents - therapeutic use | Vidarabine - analogs & derivatives | Vidarabine - therapeutic use | Granulocyte Colony-Stimulating Factor - therapeutic use | Young Adult | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Leukemia, Myeloid, Acute - drug therapy | Female | Child | Idarubicin - therapeutic use | Relapse | Chemotherapy | Anthracyclines | Granulocyte colony-stimulating factor | Influenza | Meningitis | Transplantation | Hematopoietic stem cells | Diseases | Cancer | Flow cytometry | Toxicity | Leukemia | Stem cell transplantation | Cerebrospinal fluid | Cytarabine | Granulocytes | Bone marrow | Remission | Bacteria | Colony-stimulating factor | Children | Hematology | Colonies | Myeloid leukemia | Medical treatment | Minimal residual disease | Wilms' tumor | Patients | Lymphoma | Hemopoiesis | Cytometry | Fludarabine | Anthracycline | Fatalities | Adults | Leukocytes (granulocytic) | Acute myeloid leukemia
Journal Article
Scientific Reports, ISSN 2045-2322, 12/2017, Volume 7, Issue 1, pp. 16604 - 12
Although runt-related transcription factor 1 (RUNX1) and its associating core binding factor-beta (CBFB) play pivotal roles in leukemogenesis, and inhibition... 
CBF-BETA | RUNT DOMAIN | PATHWAY | MULTIDISCIPLINARY SCIENCES | MUTATIONS | COMPLEX KARYOTYPE | BINDING | TP53 | CANCER | P53 | FAMILY | Gene silencing | Chemotherapy | Myeloid leukemia | Feedback | p53 Protein | Leukemia | Runx1 protein | Leukemogenesis | Acute myeloid leukemia
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 1409 - 1409
Background: KMT2A(MLL)-rearrangements are among the most frequent chromosomal abnormalities in acute myeloid leukemia (AML) and high EVI1 expression is known... 
Journal Article